Tour de France winner Alberto Contador and third place finisher Lance Armstrong find themselves and their team enmeshed in another controversy stemming from this year’s race. The latest incident involves French prosecutors reportedly launching a preliminary investigation into the Astana team after discovering syringes belonging to the team.
French newspaper L'Equipe reported on its website that the case was opened after “the discovery of several suspicious syringes in a container given by organizers to all the teams in order to collect the medical waste.”
The syringes will be analyzed by Toxlab, a forensic lab, to determine its content. While there were no positive tests during the Tour, one rider was suspended after the race, some drugs were seized that raised doubts about the race.
The drugs that were seized were not banned, but suspicious nonetheless for world-class athletes. The drugs included treatments for diabetes, high blood pressure and convulsions for manic-depressives.
It has been a bad week for Asanta. On top of this investigation, last week France’s anti-doping agency criticized cycling’s governing body for giving preferential treatment to Asanta by allowing Asanta to be the last team tested every day and allowing members of their team additional time to report for testing.
When the dust settles, where will Astana emerge from all the controversy?
Interact: Leave a comment and see if it gets selected for a future Shaun Talks Back (STB) column.
Follow me on Twitter.